Heidi Hunter

Heidi Hunter serves as a member of the Board of Directors for multiple companies, including IO Biotech, Bavarian Nordic, Sutro Biopharma, Inc., and Vicore Pharma AB, where Vicore focuses on drug development for lung disorders. Previously held positions include Strategic Advisor at MiGenTra GmbH and President of Cardinal Health Specialty Solutions. Hunter has extensive experience in senior leadership roles, including SVP positions at UCB and Boehringer Ingelheim, and VP roles at Quintiles and Centocor/J&J. Hunter earned an MBA from The University of Chicago Booth School of Business and a BA in Economics from the University of Michigan.